FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1222703002: Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5048580016 Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5456436018 Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5456437010 Bismuth subcitrate potassium 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) Has manufactured dose form Oral capsule true Inferred relationship Some
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation Capsule (unit of presentation) true Inferred relationship Some
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) Plays role Antibacterial therapeutic role (role) false Inferred relationship Some
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Tetracycline hydrochloride true Inferred relationship Some 1
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Tetracycline hydrochloride true Inferred relationship Some 1
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. Capsule (unit of presentation) true Inferred relationship Some 1
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Metronidazole (substance) true Inferred relationship Some 2
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Metronidazole (substance) true Inferred relationship Some 2
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. Capsule (unit of presentation) true Inferred relationship Some 2
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). biskalcitrate de bismuth false Inferred relationship Some 3
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. biskalcitrate de bismuth false Inferred relationship Some 3
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 3
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute specifies the denominator unit for the presentation strength of a product. Capsule (unit of presentation) true Inferred relationship Some 3
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Bismuth subcitrate potassium (substance) true Inferred relationship Some 3
Product containing precisely bismuth subcitrate potassium 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Bismuth subcitrate potassium (substance) true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start